ABANZA Secures FDA 510(k) Clearance for QuadLock(TM) Fixation System for ACL Reconstruction

ABANZA, a company focused on next-generation soft-tissue repair solutions, today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for QuadLock(TM), its new ...

How Sports Injuries and Minimally Invasive Care Drive $3.4 Billion U.S. Soft Tissue Repair Market? – iData Research

U.S. orthopedic soft tissue repair hit $2.3B in 2024, projected near $3.4B by 2031, driven by outpatient arthroscopy ...

BlueOcean Global Announces FDA 510(k) Clearance of the Excelsior™ External Fixation System

The Excelsior™ External Fixation System is cleared by the FDA through the 510 (k) process for its intended use and is now cleared for commercial distribution in the United States. BlueOcean Global ...